tradingkey.logo
tradingkey.logo
Search

Chemomab Therapeutics Ltd

CMMB
Add to Watchlist
1.000USD
-0.030-2.91%
Close 10-26 16:00(ET)
7.33MMarket Cap
5.74P/E TTM

Today

-2.91%

5 Days

-14.53%

1 Month

-53.70%

6 Months

-37.89%

Year to Date

-39.39%

1 Year

-69.23%

Key Figures

1.100Open
1.100High
1.40KVolume
5.74P/E TTM
LossP/E Dynamic
--Dividend TTM
0.02%Turnover Ratio
1.030Prev. Close
0.920Low
1.39KTurnover
LossP/E Static
0.84P/B
0.00%Div Yield TTM
-60.46%ROA
3.29352wk High
0.04Volume Ratio
-13.95MNet Profit
7.33MShares
0.1742EPS TTM
0.61Beta
-70.61%ROE
0.92052wk Low
23.79%Amplitude
--Gross Margin
7.33MMarket Cap
5.10Reward/Risk
6.00%Risk Rate
More news coming soon, stay tuned...

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
Strong BuyCurrent Rating
15.000Target Price
+1085.77%Upside Space
Current Rating2026-102026-092026-082026-072026-062026-052026-042026-03
Strong Buy11111111
Buy11111111
Hold00000000
Sell00000000
Strong Sell00000000

Chemomab Therapeutics Ltd Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.27/-0.15
Revenue / Forecast
--/0.00

Chemomab Therapeutics Ltd Profile

SectorBiotechnology & Medical Research
Ticker SymbolCMMB
Number of employees16
CountryIsrael

Ownership

ShareholdersProportion
Otto (Erik)5.35%
Apeiron Investment Group Ltd3.93%
Rivendell Investments 2017-9 LLC3.85%
Citadel Advisors LLC1.44%
Shareholder TypesProportion
Individual Investor7.65%
Family Office3.93%
Corporation3.85%
Hedge Fund3.27%

FAQs

What is the current price of Chemomab Therapeutics Ltd (CMMB)?

The current price of Chemomab Therapeutics Ltd (CMMB) is 1.00.

What is the symbol of Chemomab Therapeutics Ltd?

The ticker symbol of Chemomab Therapeutics Ltd is CMMB.

What is the 52-week high of Chemomab Therapeutics Ltd?

The 52-week high of Chemomab Therapeutics Ltd is 3.44.

What is the 52-week low of Chemomab Therapeutics Ltd?

The 52-week low of Chemomab Therapeutics Ltd is 0.96.

What is the market capitalization of Chemomab Therapeutics Ltd?

The market capitalization of Chemomab Therapeutics Ltd is 7.33M.

Is Chemomab Therapeutics Ltd (CMMB) currently rated as Buy, Hold, or Sell?

According to analysts, Chemomab Therapeutics Ltd (CMMB) has an overall rating of STRONG BUY, with a price target of 15.00.

What is the Earnings Per Share (EPS TTM) of Chemomab Therapeutics Ltd (CMMB)?

The Earnings Per Share (EPS TTM) of Chemomab Therapeutics Ltd (CMMB) is 0.17.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.